Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus

被引：1
|
作者：
Elsharkawy, A. M. [1 ]
机构：
[1] Univ Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 05期
关键词：
D O I：
10.1111/apt.12610
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [21] Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study
    Ogawa, E.
    Furusyo, N.
    Nakamuta, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (09) : 1076 - 1085
  • [22] Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients
    Sezaki, Hitomi
    Suzuki, Fumitaka
    Hosaka, Tetsuya
    Akuta, Norio
    Fukushima, Taito
    Hara, Tasuku
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E163 - E171
  • [23] Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection
    Martel-Laferriere, V.
    Brinkley, S.
    Bichoupan, K.
    Posner, S.
    Stivala, A.
    Perumalswami, P.
    Schiano, T. D.
    Sulkowski, M.
    Dieterich, D. T.
    Branch, A. D.
    HIV MEDICINE, 2014, 15 (02) : 108 - 115
  • [24] Improvement of Liver Stiffness Measured by ARFI During Telaprevir-Based Triple Therapy for Chronic Hepatitis C
    Kanata, Ryo
    Goto, Takashi
    Miura, Kouichi
    Ohshima, Shigetoshi
    Shibuya, Tomomi
    Sato, Wataru
    Kamada, Kentaro
    Chiba, Mitsuru
    Sakai, Toshitaka
    Minami, Shinichiro
    Sugimoto, Yuko
    Fujiwara, Junichi
    Ishioka, Mitsuaki
    Ohnishi, Hirohide
    GASTROENTEROLOGY, 2014, 146 (05) : S261 - S261
  • [25] Telaprevir-Based Treatment Effects on Hepatitis C Virus in Liver and Blood
    Talal, Andrew H.
    Dimova, Rositsa B.
    Zhang, Eileen Z.
    Jiang, Min
    Penney, Marina S.
    Sullivan, James C.
    Botfield, Martyn C.
    Chakilam, Ananthsrinivas
    Sawant, Rishikesh
    Cervini, Christine M.
    Zeremski, Marija
    Jacobson, Ira M.
    Kwong, Ann D.
    HEPATOLOGY, 2014, 60 (06) : 1826 - 1837
  • [26] Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation''
    Coilly, Audrey
    Sebagh, Mylene
    Duclos-Vallee, Jean-Charles
    JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 896 - 897
  • [27] Telaprevir-based triple therapy for hepatitis C null responders among living donor liver transplant recipients
    Kaneko, Junichi
    Sugawara, Yasuhiko
    Yamaguchi, Takamune
    Harada, Nobuhiro
    Akamatsu, Nobuhisa
    Ishizawa, Takeaki
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Tamura, Sumihito
    Tanaka, Tomohiro
    Kokudo, Norihiro
    BIOSCIENCE TRENDS, 2014, 8 (06) : 339 - 345
  • [28] A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapy
    Takayama, Koji
    Furusyo, Norihiro
    Ogawa, Eiichi
    Shimizu, Motohiro
    Hiramine, Satoshi
    Mitsumoto, Fujiko
    Ura, Kazuya
    Toyoda, Kazuhiro
    Murata, Masayuki
    Hayashi, Jun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (9-10) : 577 - 581
  • [29] Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response
    Furusyo, Norihiro
    Ogawa, Eiichi
    Murata, Masayuki
    Toyoda, Kazuhiro
    Ohnishi, Hachiro
    Eiraku, Kunimitsu
    Shimizu, Motohiro
    Harada, Yuji
    Mitsumoto, Fujiko
    Takayama, Koji
    Kainuma, Mosaburo
    Okada, Kyoko
    Hayashi, Jun
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) : 483 - 490
  • [30] Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis
    T. Tieghi
    R. Marocco
    V. Belvisi
    C. Del Borgo
    S. Savinelli
    M. Lichtner
    C. M. Mastroianni
    Infection, 2014, 42 : 225 - 226
12345